Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: A 14-year follow-up of a randomized primary HPV screening trial

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

(2014) K. M. Elfstrom et al.   BMJ-British Medical Journal

The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3

(2013) Rogier J.N.T.M. Litjens et al.   HUMAN PATHOLOGY

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types

(2013) Davit Bzhalava et al.   VIROLOGY

The 2010 Global Proficiency Study of Human Papillomavirus Genotyping in Vaccinology

(2012) C. Eklund et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Type-Specific Detection of 30 Oncogenic Human Papillomaviruses by Genotyping both E6 and L1 Genes

(2012) J. Peng et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial

(2012) Francesca Carozzi et al.   LANCET ONCOLOGY

Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries

(2012) Karen Canfell et al.   VACCINE

Global Burden of Human Papillomavirus and Related Diseases

(2012) David Forman et al.   VACCINE

A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study

(2011) M. Schiffman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)

(2010) Gina S Ogilvie et al.   BMC CANCER

Prospective Study of Human Papillomavirus (HPV) Types, HPV Persistence, and Risk of Squamous Cell Carcinoma of the Cervix

(2010) K. Sundstrom et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prospective study of human papillomavirus and risk of cervical adenocarcinoma

(2010) Lisen Arnheim Dahlström et al.   INTERNATIONAL JOURNAL OF CANCER

Global Proficiency Study of Human Papillomavirus Genotyping

(2010) C. Eklund et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus

(2009) A. Soderlund-Strand et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial

(2008) A Sargent et al.   BRITISH JOURNAL OF CANCER

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

(2008) V M H Coupé et al.   BRITISH JOURNAL OF CANCER

Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland

(2008) Maarit Leinonen et al.   INTERNATIONAL JOURNAL OF CANCER